Education
About Us
Working with TipRanks
Follow Us
Infant Bacterial Therapeutics AB (DE:9IB)
BERLIN:9IB
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | kr 0.00 | kr 77.00K | kr 12.00K | kr 0.00 | kr 0.00 |
| Gross Profit | kr 0.00 | kr 77.00K | kr 12.00K | kr 0.00 | kr 0.00 |
| Operating Income | kr -139.90M | kr -134.62M | kr -65.81M | kr -44.58M | kr -71.92M |
| EBITDA | kr -136.91M | kr 11.55M | kr -65.45M | kr -44.99M | kr -72.01M |
| Net Income | kr -136.91M | kr -123.07M | kr -65.09M | kr -45.40M | kr -72.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | kr 223.39M | kr 329.06M | kr 335.84M | kr 386.75M | kr 423.44M |
| Total Assets | kr 239.57M | kr 351.33M | kr 349.62M | kr 408.48M | kr 450.32M |
| Total Debt | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 | kr 0.00 |
| Net Debt | kr -223.39M | kr -329.06M | kr -335.84M | kr -386.75M | kr -423.44M |
| Total Liabilities | kr 69.30M | kr 46.18M | kr 17.91M | kr 13.22M | kr 10.16M |
| Stockholders' Equity | kr 170.26M | kr 305.15M | kr 331.71M | kr 395.25M | kr 440.15M |
| Cash Flow | |||||
| Free Cash Flow | kr -113.13M | kr -101.22M | kr -85.80M | kr -55.62M | kr -58.39M |
| Operating Cash Flow | kr -113.13M | kr -101.22M | kr -85.80M | kr -55.62M | kr -58.39M |
| Investing Cash Flow | kr 0.00 | kr -4.15M | kr -1.00K | kr 0.00 | kr 0.00 |
| Financing Cash Flow | kr 2.01M | kr 96.52M | kr 1.88M | kr 91.00K | kr 1.76M |
Infant Bacterial Therapeutics AB Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.